GRPR and Alzheimer disease: Thus, our group has put forward the GRPR as a noveltherapeutic target for the development of therapies to treat neurological andpsychiatric disorders.4,17 The present study reviews currentevidence suggesting the GRPR should be considered a target for the treatment ofcognitive dysfunction in patients with AD.